Janssen announces new group to tackle global health
Tuesday, January 28, 2014
The new group, known as Janssen GPH, will oversee R&D and access strategy development for Janssen’s growing portfolio of transformational medicines in markets with great unmet public health need.
“With this new group, we’ve adopted a more focused approach to further develop and introduce our most promising medicines, and look forward to advancing a sustainable platform that will make a significant impact on the lives of people around the world,” said Janssen chairman Paul Stoffels.
Source: PM Live (link opens in a new window)
- Education, Health Care
- product design, research